T cell-mediated tumor killing patterns in head and neck squamous cell carcinoma identify novel molecular subtypes, with prognosis and therapeutic implications
Z Meng, L Zhu, W Liu, W Yang, Y Wang - Plos one, 2023 - journals.plos.org
As an important process in cancer immunotherapy, T cell-mediated tumor killing (TTK)
enhances the immune response of patients. However, the role of TTK in Head and Neck …
enhances the immune response of patients. However, the role of TTK in Head and Neck …
[HTML][HTML] Optimized radiotherapy treatment strategy for early glottic carcinoma
T Ono, Y Itoh, S Ishihara, M Kawamura… - Nagoya Journal of …, 2023 - ncbi.nlm.nih.gov
The local control rates of T1 bulky and T2 glottic carcinoma treated via radiation therapy
alone are unsatisfactory; thus, we aimed to evaluate the efficacy and safety of our treatment …
alone are unsatisfactory; thus, we aimed to evaluate the efficacy and safety of our treatment …
Preoperative S-1 Therapy for Head and Neck Carcinoma During the Waiting Period Before Surgery
T Matsuki, C Fushimi, S Miyamoto… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: In patients with squamous cell carcinoma of the head and neck (SCCHN),
delayed surgery can result in poorer postoperative function and prognosis due to the growth …
delayed surgery can result in poorer postoperative function and prognosis due to the growth …
[引用][C] Evaluation of the Immunogenicity of a Novel Combination Strategy for Head and Neck Squamous Cell Carcinoma in 3D Tumor Models: Innovative Non-Thermal …
M Bauwens